2023 Focused Update of the 2021 ESC Guidelines for the …
2023年8月25日 · This 2023 Focused Update addresses changes in recommendations for the treatment of heart failure (HF) because of several randomized controlled trials since the publication of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. HFmrEF, HFpEF, comorbidities and Acute HF.
2021 ESC Guidelines for the diagnosis and treatment of acute and ...
This guideline provides practical, evidence-based recommendations. The format of the previous 2016 ESC HF Guidelines was revised to make each phenotype of HF stand alone in terms of its diagnosis and management. The therapy recommendations mention the treatment effect supported by the class and level of evidence and are presented in tables.
Finerenone improves outcomes in a common type of heart failure
2024年9月1日 · There are limited treatment options for the large population of patients with heart failure (HF) and mildly reduced or preserved ejection fraction (HFmrEF/HFpEF). In the FINEARTS-HF trial, finerenone reduced HF events and cardiovascular death in patients with HFmrEF/HFpEF.
2021 ESC Guidelines for the diagnosis and treatment of acute …
2021年8月27日 · The risk of HF hospitalization is 1.5 times higher in patients with diabetes compared to controls. AF, a higher body mass index (BMI), and higher glycated haemoglobin (HbA1c), as well as a low estimated glomerular filtration rate (eGFR) are strong predictors of HF hospitalizations.29.
2023 Focused Update of the 2021 ESC Guidelines for the …
2023年8月25日 · In addition to selecting the trials to be included, the Task Force also discussed changing the description of HF with preserved ejection fraction (HFpEF) to HF with normal ejection fraction (HFnEF) and the left ventricular ejection fraction (LVEF) threshold for HFnEF.
ESC Consensus on HFpEF Diagnosis: Key Points
2019年10月28日 · A rest pulmonary capillary wedge pressure (PCWP) ≥15 mm Hg or exercise PCWP ≥25 mm Hg is diagnostic of HFpEF. The final step consists of establishing HFpEF etiology. This includes assessment of blood pressure control, chronotropic competence, arrhythmias, and …
Heart failure with preserved ejection fraction: everything the ...
2024年3月16日 · The diagnosis of HFpEF might be fairly straightforward in patients with overt physical examination signs of congestion on physical examination (eg, pitting leg oedema and pulmonary crackles), elevated natriuretic peptide levels (ESC criteria of NT-proBNP >125 pg/mL sinus rhythm) or atrial fibrillation (>365 pg/mL), brain natriuretic peptide ...
2021 ESC Guidelines for the diagnosis and treatment of acute and ...
HFpEF: Screening for, and treatment of, aetiologies, and CV and non-CV comorbidities are recommended in patients with HFpEF (see relevant sections of this document). I: Prevention and monitoring: Self-management strategies are recommended to …
How to diagnose heart failure with preserved ejection fraction: the …
Selected experts in the field undertook a comprehensive review of the published evidence for diagnosis of HFpEF according to the ESC Committee for Practice Guidelines (CPG) and HFA policy. A critical evaluation of suggested procedures …
How to diagnose heart failure with preserved ejection fraction …
2019年10月21日 · In the absence of overt non-cardiac causes of breathlessness, HFpEF can be suspected if there is a normal left ventricular ejection fraction, no significant heart valve disease or cardiac ischaemia, and at least one typical risk factor.